BlueCrest Capital Management’s Labcorp LH Stock Holding History

BlueCrest Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,449	Closed	-$453K	–	773
2019 Q1	$453K	Buy	+3,449	New	+$425K	0.02%	526
2018 Q3	–	Sell	-2,132	Closed	-$329K	–	1668
2018 Q2	$329K	Buy	+2,132	New	+$322K	0.01%	1044
2018 Q1	–	Sell	-128,584	Closed	-$17.6M	–	1568
2017 Q4	$17.6M	Buy	+128,584	New	+$17M	0.48%	34
2016 Q1	–	Sell	-6,325	Closed	-$672K	–	972
2015 Q4	$672K	Buy	+6,325	New	+$653K	0.03%	506
2015 Q2	–	Sell	-12,302	Closed	-$1.33M	–	861
2015 Q1	$1.33M	Buy	+12,302	New	+$1.27M	0.07%	323

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlueCrest Capital Management's LH Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Labcorp (LH) in Q2 2019, closing a stake of 3,449 shares — an estimated $453K sold.

BlueCrest Capital Management first reported a position in LH in Q1 2015 and held it in 5 quarters. The position peaked at $17.6M in Q4 2017. 741 funds tracked by Wall St. Rank hold LH as of Q2 2019.

BlueCrest Capital Management reported no remaining Labcorp position as of Q2 2019 after selling out during the quarter.
BlueCrest Capital Management sold 3,449 Labcorp shares in Q2 2019, an estimated $453K.
BlueCrest Capital Management first reported a position in Labcorp in Q1 2015 and held it in 5 quarters.
BlueCrest Capital Management's Labcorp position peaked at $17.6M in Q4 2017.
741 funds tracked by Wall St. Rank held Labcorp as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.